On Sunday morning at the San Diego Convention Center, every attendee seated in Hall H for the Opening Ceremony and…
Read More
Pfizer and Astellas Secure FDA Priority Review for Perioperative Padcev and Keytruda Combination in Muscle-Invasive Bladder Cancer
The United States Food and Drug Administration (FDA) has granted priority review to a supplemental biologics license application (sBLA) from…
Read More
Cancer Scientists Unanimously Advocate for Sustained Congressional Funding at AACR Annual Meeting in San Diego
On Sunday morning, at the bustling San Diego Convention Center, a powerful demonstration of unity and gratitude unfolded as attendees…
Read More
Fully defined 3D culture substrate for cancer research
Oxford, UK – AMSBIO, a leading innovator in life sciences, has announced a significant advancement in cancer research, reporting that…
Read More
Small Study Suggests Probiotic Yogurt Strain May Boost Immunotherapy Response in Lung Cancer
The landscape of lung cancer treatment has undergone a significant transformation with the advent of immunotherapy, offering renewed hope and…
Read More
Advancing Cancer Research and Life Sciences: Insights from AACR and North American Innovation Landscape
The American Association for Cancer Research (AACR) Annual Meeting, held this year in San Diego, CA, USA, from April 17–22,…
Read More
How breast cancer cells survive in bone marrow after remission
The study, published in the Journal of Clinical Investigation, identifies a sophisticated "smuggling" operation between cancer cells and the bone…
Read More
Breakthrough Human-Only Bone Marrow Model Paves the Way for Advanced Blood Cancer Research and Reduced Animal Testing
In a significant leap for regenerative medicine and hematology, researchers at the University of Basel and University Hospital Basel have…
Read More
Ludwig Cancer Research Unveils Synergistic Combination Therapy Targeting Differentiation Blockade in Acute Myelogenous Leukemia
The landscape of hematological oncology is facing a potential paradigm shift following a landmark study by Ludwig Cancer Research, which…
Read More
AI-Powered "GPS" Model Marks Paradigm Shift in Drug Discovery, Identifies Candidates for Liver Cancer and Pulmonary Fibrosis
A groundbreaking machine-learning model, dubbed "GPS" (Gene Expression Profile Predictor on Chemical Structures), has been unveiled by a multi-institute collaboration…
Read More
